Discovery of an HSP90-Modulating Amphiphilic Peptide Dendrimer as a Bioactive Carrier for Combination Cancer Therapy
Conventional single-target drugs frequently suffer from limited efficacy and drug resistance. Here, we report an amphiphilic peptide dendrimer that integrates intrinsic bioactivity and nanocarrier functions, establishing a novel “drug-bioactive carrier” paradigm for multi-target cancer therapy. Using reverse molecula...